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Background: Hyponatremia is associated with increased mortality in chronic kidney disease with and without
end-stage renal disease (ESRD). Increasing evidence suggests that hyponatremia is not only a marker of severe
underlying disease, but also a direct contributor to mortality. However, specific pathogenesis or diseases
contributing to mortality in the hyponatremic population are unknown. This study aimed to clarify the relationship
between serum sodium level (sNa) and infection risk in ESRD patients.
Methods: This observational cohort study included 332 patients on maintenance hemodialysis in our dialysis unit
in May 2009. The mean of 3 monthly measurements of glucose-corrected sNa before each dialysis session in May,
June, and July 2009 was applied as baseline sNa. The primary endpoint was first infection-related hospitalization
(IRH), and the secondary endpoint was death of any cause. Data were analyzed using Cox hazards modeling,
adjusted for baseline demographics and characteristics, or laboratory data. Patients were followed until transfer,
kidney transplantation, death, or study end on January 31, 2013.
Results: Mean sNa was 138.9 mEq/L (1st tertile: <138.0, n = 104; 2nd tertile: 138.0–140.0, n = 116; 3rd tertile: >140.0,
n = 112). During 39.5 months’ mean follow-up, 57 patients experienced IRH (56.4/1,000 patient-years overall;
89.7/1,000 in 1st tertile; 57.9/1,000 in 2nd tertile; 28.0/1,000 in 3rd tertile), and 68 patients died. The hazard ratio
(HR) for IRH was higher for the 1st and 2nd tertiles than the 3rd tertile (unadjusted HR, 3.20; 95% confidence interval
(CI), 1.54–6.64; p = 0.002; adjusted HR, 2.36; 95% CI, 1.10–5.04; p = 0.027; and unadjusted HR, 2.07; 95% CI, 0.98–4.40;
p = 0.058; adjusted HR, 2.11; 95% CI, 0.99–4.51; p = 0.054 respectively). In a continuous model, higher sNa was
associated with lower risk of IRH (adjusted HR, 0.90; 95% CI, 0.81–0.99; p = 0.040), and lower all-cause mortality
(adjusted HR, 0.91; 95% CI, 0.83–1.00; p = 0.049).
Conclusions: Lower sNa is an independent predictor of higher risk for infection-related hospitalization in
maintenance hemodialysis patients. Infectious disease may partially account for the increased mortality observed
in the hyponatremic population with ESRD.
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Hyponatremia is among the most common electrolyte
disorders in clinical practice, particularly in hospitalized
patients, 15% to 40% of whom have hyponatremia, de-
pending on the definition [1,2]. The relationship between
hyponatremia and increased mortality has been recog-
nized, primarily in patients with heart failure and liver
cirrhosis [3-7]. Recent studies have additionally revealed
this association in a wide variety of diseases including
myocardial infarction [2,8], pulmonary embolism [9],
cancer [2,10] and pneumonia [11], and in patients in
perioperative settings [1,12] and those in intensive care
units [13]. Similar observations have been made in chronic
kidney disease (CKD) patients with [14-16] and without
end-stage renal disease (ESRD) [17]. These studies have
identified hyponatremia as an independent predictor of
mortality after adjustments for potential confounders
reflecting severity of underlying disease, and thus sug-
gested that hyponatremia is not only a marker of severe
underlying disease, but also a direct contributor to mortal-
ity. However, it has yet to be clarified how hyponatremia
contributes to mortality, or which disease is responsible
for increased mortality in the hyponatremic population.
Previous data which answer this question are very limited,
but Waikar et al. [14] showed that the relationship
between lower sNa and higher mortality was not signifi-
cant in analyses of cardiovascular mortality, but rather,
was significant in analyses of non-cardiovascular mortality
in maintenance hemodialysis (HD) patients. We hypothe-
sized that hyponatremia is associated with increased sus-
ceptibility to infection, and infectious disease additionally
contribute to mortality in the hyponatremic population.
This study aimed to investigate the relationship between
sNa and the future risk of hospitalization due to infectious
disease in patients with ESRD.
Methods
Study population
In May 2009, 381 patients underwent maintenance HD
in our dialysis unit. The study participants included 354
patients whose HD vintage was 12 months or more.
Participants were excluded if patients lacked at least one
measurement among the 3 monthly routine laboratory
measurements before each dialysis session in May, June,
and July 2009 (n = 12), or an observational period was
less than 6 months (n = 10). The remaining 332 patients
were enrolled in this study. All patients received thrice-
weekly HD. Cardiovascular disease (CVD) was defined
as myocardial infarction, coronary revascularization, or
hospitalization for heart failure. Peripheral vascular
disease was defined as revascularization of arteries distal
to the common iliac artery or amputation. Cerebrovas-
cular disease was defined as cerebral infarction, cerebral
hemorrhage, or subarachnoid hemorrhage. Chronic liverdisease was defined as liver cirrhosis or chronic viral
hepatitis. Dialysis vintage was defined as time from
initiation of HD until May 1, 2009, or from that of
peritoneal dialysis if patients had undergone peri-
toneal dialysis before switching to HD. Intradialytic
weight loss (IDWL) (% per body weight) was calculated
according to an equation: IDWL= intradialytic filtration
volume in kg/post-dialytic body weight in kg × 100. In our
dialysis unit, regular blood sampling was conducted
monthly before the first dialysis session in a week
(on Mon or Tue). The sNa was measured in our hospi-
tal’s clinical laboratory using an electrode-sensitive assay
(CA-25011, JEOL Ltd., Japan), and precision measurement
and calibration are routinely conducted every day. Al-
though data in 2009 were not available, the latest data of
30 measurements during September 2013 were available:
the mean value of the lower-concentration standard
solution widely used in Japan (mean value of the previous
cumulative measurements using the same method at
multiple centers in Japan, 132.37 mEq/L) was 131.70 ±
0.64 mEq/L (95% confidence interval, 131.46–131.94), and
that of the higher-concentration standard solution (mean
value of the previous cumulative measurements at
multiple centers in Japan, 150.05 mEq/L) was 149.28 ±
0.49 mEq/L (95% confidence interval, 149.10–149.46).
The sNa was adjusted with the paired serum glucose level
if the serum glucose level was over 200 mg/dL (1.6 mEq/L
per 100 mg/dL) [18]. The mean of the 3 monthly
measurements of body mass index (BMI), IDWL, and
laboratory data was applied as each baseline value, with
the exception of β2-microglobulin (β2-MG), which was
measured routinely once in 3 months in all partici-
pants. Patients were followed from May 1, 2009 until
transfer, kidney transplant, death, or study end on
January 31, 2013.
This study protocol was approved by the ethics
committee of Shuuwa General Hospital, and the study
was preformed in accordance with the Declaration of
Helsinki guidelines regarding ethical principles for
medical research involving human subjects. Informed
consent was obtained by all participants after informa-
tion about the study was displayed in poster format in a
public space.
Outcomes
The primary outcome was time to first infection-related
hospitalization (IRH) after the 3rd laboratory measure-
ment in July 2009. Events after the second event were
not included in the analysis. IRH was defined when
primary diagnosis on admission was infectious disease as
noted in medical records. IRHs were divided into seven
exclusive categories: pulmonary infections (e.g., pneu-
monia, bronchopneumonia), gastrointestinal infections
(e.g., appendicitis, enterocolitis, cholecystitis, cholangitis),
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tatitis), soft tissue infections (e.g., cellulitis), joint or bone
infections (e.g., septic arthritis, osteomyelitis), septicemia,
and others. Catheter-related bloodstream infection and
graft infection were categorized as septicemia. The
secondary outcome was death of any cause.
Statistical analysis
Data are described as means and standard deviations for
continuous variables, or numbers and percentages for
categorical variables. The association of baseline demo-
graphics and characteristics, or laboratory data with sNa,
was examined using univariate and multivariate linear
regression analyses. In multivariate analyses, covariates
included those that were statistically correlated with
baseline sNa with p < 0.05 at univariate analyses. Kaplan-
Meier curves were used for analysis of time to first IRH
or death of any cause. Predictors of outcomes wereTable 1 Baseline demographics and characteristics of the stud
Whole group 1st tert
Number of patients, n (%) 332 (100) 10
Age (years) 61.6 ± 12.6 62.3
Female, n (%) 121 (36) 34
Body mass index (kg/m2) 21.2 ± 3.6 20.
Smoking history, n (%) 118 (36) 38
Inability to ambulate or transfer, n (%) 28 (8) 11
Comorbid conditions
Diabetes mellitus, n (%) 120 (36) 51
Hypertension, n (%) 310 (93) 10
Cardiovascular disease, n (%) 101 (30) 42
Peripheral vascular disease, n (%) 16 (5) 9
Cerebrovascular disease, n (%) 47 (14) 19
Chronic liver disease, n (%) 37 (11) 11
Cancer, n (%) 43 (13) 7
Dialysis vintage (months) 124 ± 96 10
IDWL (% of body weight) 5.1 ± 1.3 5.6
Vascular access
Fistula 290 (87) 88
Graft 38 (12) 16
Catheter 4 (1) 0
Laboratory data
Serum sodium (mEg/L) 138.9 ± 2.6 136
Hemoglobin (g/dL) 10.5 ± 0.9 10.
Serum albumin (g/dL) 3.8 ± 0.3 3.8
Serum creatinine (mg/dL) 11.7 ± 2.8 11.
Serum β2-microglobulin (mg/dL) 27.3 ± 5.3 28.
Values are expressed as mean ± SD for continuous variables, or numbers and perce
Abbreviations: IDWL intradialytic weight loss.evaluated using Cox hazards modeling adjusted for sNa,
all covariates, which were correlated to the outcomes
with p < 0.001 at univariate analyses, and also the deter-
minants of baseline sNa at multivariate linear regression
analyses.
Statistical analyses were performed with Dr. SPSS II
for Windows, a software package based on SPSS 11.0 J
for Windows (SPSS, Chicago, IL, USA). P-values < 0.05
were considered significant for all analyses.
Results
General characteristics of participants
In total, 332 HD patients were enrolled into this study.
The baseline demographics and characteristics are
shown in Table 1. The mean age of the study subjects
was 61.6 ± 12.6 years, 36% of the study subjects were
female, 36% were current or past smokers, 8% were not
able to ambulate or transfer, 36% had diabetes mellitusy participants
Serum sodium level tertile (mEq/L)
ile <138.0 2nd tertile 138.0 – 140.0 3rd tertile >140.0
4 (31) 116 (35) 112 (34)
± 14.2 60.6 ± 12.0 61.9 ± 11.5
(33) 41 (35) 46 (41)
9 ± 4.1 21.2 ± 3.4 21.5 ± 3.3
(37) 39 (34) 41 (37)
(11) 9 (8) 8 (7)
(49) 36 (31) 33 (29)
0 (96) 105 (91) 105 (94)
(40) 30 (26) 29 (26)
(9) 4 (3) 3 (3)
(18) 13 (11) 15 (13)
(11) 13 (11) 13 (12)
(7) 16 (14) 20 (18)
2 ± 79 135 ± 94 134 ± 108
± 1.4 5.0 ± 1.3 4.8 ± 1.2
(85) 103 (89) 99 (88)
(15) 12 (10) 10 (9)
(0) 1 (1) 3 (3)
.0 ± 1.8 139.0 ± 0.7 141.5 ± 1.1
7 ± 1.1 10.5 ± 0.9 10.4 ± 0.8
± 0.3 3.9 ± 0.3 3.8 ± 0.3
4 ± 3.0 12.1 ± 2.8 11.7 ± 2.7
0 ± 4.9 27.2 ± 5.8 26.6 ± 5.1
ntages for categorical variables.
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were categorized into three groups based on sNa; 1st
tertile: < 138.0 mEq/L, n = 104; 2nd tertile: 138.0–
140.0 mEq/L, n = 116; 3rd tertile: > 140.0 mEq/L, n = 112.
Determinants of baseline serum sodium level
In univariate linear regression analyses, DM, CVD,
cancer, dialysis vintage, IDWL, hemoglobin, and serum
albumin were correlated with baseline sNa (Table 2). In
multivariate analyses, cancer and serum albumin were
positively correlated, and IDWL and hemoglobin were
negatively correlated with sNa (Table 2).
Primary outcome
During a mean follow-up of 39.5 months, 57 patients ex-
perienced at least one IRH (incidence rate: 56.4/1,000
patient-years overall; 89.7/1,000 in sNa 1st tertile; 57.9/
1,000 in 2nd tertile; 28.0/1,000 in 3rd tertile). The
incidence rate of each IRH subtype is shown in Figure 1.
Pulmonary infections were the most common type ofTable 2 Determinants of baseline serum sodium level
Univ
Coefficient
Age (per 5 years) −0.008
Female (vs male) 0.426
Body mass index (per 1 kg/m2) 0.004
Smoking history −0.078





Peripheral vascular disease −1.139
Cerebrovascular disease −0.158
Chronic liver disease −0.395
Cancer 1.185
Dialysis vintage (per 12 months) 0.045
IDWL (per 1% of body weight) −0.554
Vascular access
Fistula 0 (ref)
Graft or catheter −0.408
Laboratory data
Hemoglobin (per 1 g/dL) −0.357
Serum albumin (per 1 g/dL) 1.122
Serum creatinine (per 1 mg/dL) 0.041
Serum β2-microglobulin (per 5 mg/dL) −0.249
aAdjustments in all covariates, which were significantly correlated with baseline ser
mellitus, cardiovascular disease, cancer, dialysis vintage, IDWL, hemoglobin, and ser
Abbreviations: IDWL intradialytic weight loss.infection among the HD patients in this study. The types
of IRH having the highest incidence in the 1st tertile
were observed to be pulmonary infections, gastrointes-
tinal infections, genitourinary infections, and soft tissue
infections.
The lower sNa tertiles were significantly associated
with higher risk of IRH (Figure 2A). More IRH events
occurred in the 1st and 2nd tertiles than in the 3rd ter-
tile at univariate and multivariate Cox models (Table 3).
When sNa was considered as a continuous variable,
lower sNa was associated with higher risk of IRH
(Table 3). CVD, and graft or catheter were also associ-
ated with increased risk of IRH.
Secondary outcome
During follow-up, 68 patients died. The association of
sNa tertile with all-cause mortality was statistically sig-
nificant (Figure 2B). When sNa was considered as a con-
tinuous variable, the relationship between lower sNa and





















um sodium level, with p < 0.05 at univariate analyses including diabetes
um albumin.
Figure 2 Kaplan-Meier curves of time to outcomes according to
serum sodium level tertiles. (A) First infection-related
hospitalization. (B) Death of any cause. Abbreviations: sNa, serum
sodium level.
Figure 1 Incidence rate of each subtype of infection-related
hospitalization according to serum sodium level tertiles.
Abbreviations: IRH, infection-related hospitalization; sNa, serum
sodium level.
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ated with increased all-cause mortality. The association
of CVD with increased all-cause mortality was margin-
ally significant.
Discussion
The principal finding in the current study is that lower
sNa is an independent predictor of higher risk for
infection-related hospitalization in maintenance HD pa-
tients. To the best of our knowledge, this study is the
first to investigate the relationship between sNa and risk
of infection in patients with ESRD. Although increasing
evidence indicates a possible causal relationship between
sNa and mortality, specific pathogenesis or diseases con-
tributing to mortality in the hyponatremic population
have yet to be clarified. Infectious disease may partially
account for the increased mortality observed in hypona-
tremic subjects with ESRD.
The present study showed that lower sNa is an inde-
pendent predictor of higher risk for infection in ESRD
patients, and confirmed the established relationship be-
tween lower sNa and higher mortality, even after adjust-
ments for various covariates. Prior studies have shown
an association between hyponatremia and increased
mortality in a wide variety of diseases [3-11]. However,
in the majority of these studies, baseline sNa was based
on measurements during hospitalization and/or in the
acute phase of underlying disease, and these settings are
more likely to increase either an appropriate or inap-
propriate secretion of arginine vasopressin (antidiuretic
hormone, ADH), resulting in higher reabsorption of
solute-free water with a lower level of sNa. In contrast,recent large cohort studies in the general population
[19,20] or in CKD patients [17] have shown that chronic
and mild hyponatremia are associated with increased all-
cause mortality, even after adjustments for potential
confounders or underlying disease. Furthermore, Waikar
et al. [14] showed a continuous relationship between
lower sNa and higher mortality in the HD population
without residual renal function, indicating that this
relationship is independent of ADH secretion related to
underlying disease. Thus, it is possible that hyponatre-
mia is not only a marker of severe underlying disease
that results in poor outcome, but is also a direct con-
tributor to mortality [21]. Similarly, our findings from
the HD population suggest that hyponatremia possibly
results in increased susceptibility to infection, and infec-
tious disease additionally contributes increased mortality
in hyponatremic subjects with ESRD. Although several
studies of the HD population have not clarified specific
diseases that are responsible for increased mortality in
hyponatremic subjects [14-16], the HEMO study showed
that the relationship between lower sNa and higher
Table 3 Predictors of infection-related hospitalization in the study population
Univariate Multivariatea
HR (95% CI) p-value HR (95% CI) p-value
Serum sodium level
Categorical model
<138.0 mEq/L 3.20 (1.54–6.64) 0.002 2.36 (1.10–5.04) 0.027
138.0 – 140.0 mEq/L 2.07 (0.98–4.40) 0.058 2.11 (0.99–4.51) 0.054
>140.0 mEq/L 1 (ref) 1 (ref)
Continuous model (per 1 mEq/L) 0.86 (0.79–0.94) <0.001 0.90 (0.81–0.99) 0.040
Age (per 5 years) 1.06 (0.95–1.18) 0.318
Female (vs male) 1.31 (0.78–2.22) 0.313
Body mass index (per 1 kg/m2) 0.99 (0.91–1.07) 0.711
Smoking history 1.52 (0.90–2.56) 0.120
Inability to ambulate or transfer 4.79 (2.61–8.80) <0.001 2.10 (0.90–4.91) 0.086
Comorbid conditions
Diabetes mellitus 1.66 (0.99–2.80) 0.056
Hypertension 0.65 (0.28–1.51) 0.313
Cardiovascular disease 2.54 (1.51–4.27) <0.001 2.21 (1.30–3.75) 0.003
Peripheral vascular disease 1.83 (0.66–5.07) 0.243
Cerebrovascular disease 1.65 (0.86–3.19) 0.135
Chronic liver disease 1.08 (0.49–2.39) 0.846
Cancer 1.01 (0.46–2.23) 0.976
Dialysis vintage (per 12 months) 0.98 (0.95–1.01) 0.242
IDWL (per 1% of body weight) 1.05 (0.86–1.28) 0.651
Vascular access
Fistula 1 (ref) 1 (ref)
Graft or catheter 4.08 (2.33–7.15) <0.001 2.95 (1.57–5.55) 0.001
Laboratory data
Hemoglobin (per 1 g/dL) 0.80 (0.59–1.08) 0.140
Serum albumin (per 1 g/dL) 0.16 (0.07–0.37) <0.001 0.47 (0.15–1.45) 0.186
Serum creatinine (per 1 mg/dL) 0.84 (0.76–0.92) <0.001 0.97 (0.86–1.10) 0.654
Serum β2-microglobulin (per 5 mg/dL) 1.26 (1.01–1.57) 0.037
aAdjustments in serum sodium level, all covariates, which were correlated with the outcome, with p < 0.001 at univariate analyses including inability to ambulate
or transfer, cardiovascular disease, graft or catheter, serum albumin, and serum creatinine, and also determinants of baseline serum sodium level at multivariate
linear regression analyses including cancer, IDWL, and hemoglobin.
Abbreviations: CI confidence interval, HR hazard ratio, IDWL intradialytic weight loss.
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lar mortality, but rather, was significant in analyses of
non-cardiovascular mortality [14]. The findings of the
present study may explain these observations.
Hyponatremia is a relatively frequent complication
observed in infectious disease, especially in tuberculosis
[22], pneumonia [11], human immunodeficiency virus
infection [23], and bacterial meningitis [24], and the
association of hyponatremia with increased mortality in
these diseases has been identified. It is well known that
infection can result in hyponatremia through various
pathopysiological mechanisms including hypovolemia,
hyperglycemia, renal failure, heart failure, or syndromeof inappropriate ADH secretion, but it has been un-
known whether the existence of hyponatremia predicts
infection. Of note is that the findings of the present
study showed that subjects with lower sNa are more
likely to develop infectious disease, although the study
population was specific. Previously, a number of studies
examined risk factors for IRH or infectious death in
ESRD patients, but no studies considered sNa as a co-
variate related to risk for infection. However, the present
study included almost all covariates that are known risk
factors including age [25-28], DM [25-27], CVD [26],
inability to ambulate or transfer [26], vascular access [25],
hemoglobin [26], serum albumin [25-28], and serum
Table 4 Predictors of all-cause mortality in the study population
Univariate Multivariatea
HR (95% CI) p-value HR (95% CI) p-value
Serum sodium level
Categorical model
<138.0 mEq/L 2.06 (1.15–3.66) 0.014 1.57 (0.85–2.87) 0.148
138.0 – 140.0 mEq/L 0.94 (0.49–1.81) 0.853 0.97 (0.50–1.89) 0.938
>140.0 mEq/L 1 (ref) 1 (ref)
Continuous model (per 1 mEq/L) 0.87 (0.81–0.95) 0.001 0.91 (0.83–1.00) 0.049
Age (per 5 years) 1.40 (1.25–1.57) <0.001 1.24 (1.08–1.41) 0.002
Female (vs male) 0.76 (0.46–1.28) 0.302
Body mass index (per 1 kg/m2) 0.88 (0.81–0.95) 0.001
Smoking history 1.32 (0.81–2.13) 0.267
Inability to ambulate or transfer 4.13 (2.32–7.36) <0.001 1.44 (0.69–2.99) 0.328
Comorbid conditions
Diabetes mellitus 2.80 (1.73–4.54) <0.001 1.98 (1.17–3.36) 0.011
Hypertension 1.66 (0.52–5.30) 0.388
Cardiovascular disease 2.36 (1.47–3.80) <0.001 1.65 (0.98–2.76) 0.059
Peripheral vascular disease 3.84 (1.90–7.75) <0.001 1.89 (0.88–4.06) 0.104
Cerebrovascular disease 2.07 (1.18–3.63) 0.011
Chronic liver disease 1.63 (0.85–3.10) 0.140
Cancer 2.82 (1.65–4.84) <0.001 2.49 (1.39–4.46) 0.002
Dialysis vintage (per 12 months) 0.99 (0.95–1.02) 0.357
IDWL (per 1% of body weight) 1.02 (0.85–1.23) 0.824
Vascular access
Fistula 1 (ref)
Graft or catheter 2.14 (1.20–3.79) 0.010
Laboratory data
Hemoglobin (per 1 g/dL) 0.82 (0.62–1.07) 0.140
Serum albumin (per 1 g/dL) 0.16 (0.08–0.32) <0.001 0.65 (0.24–1.74) 0.388
Serum creatinine (per 1 mg/dL) 0.76 (0.69–0.83) <0.001 0.93 (0.81–1.06) 0.272
Serum β2-microglobulin (per 5 mg/dL) 1.26 (1.03–1.54) 0.027
aAdjustments in serum sodium level, all covariates, which were correlated with the outcome, with p < 0.001 at univariate analyses including age, inability to
ambulate or transfer, diabetes mellitus, cardiovascular disease, peripheral vascular disease, cancer, serum albumin, and serum creatinine, and also determinants of
baseline serum sodium level at multivariate linear regression analyses including IDWL and hemoglobin.
Abbreviations: CI confidence interval, HR hazard ratio, IDWL intradialytic weight loss.
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have shown that hyponatremia can be a risk of infec-
tion, but the data are very limited. In an analysis of
perioperative patients, preoperative hyponatremia pre-
dicted wound infections and pneumonia [12]. Jensen et al.
showed that hyponatremia was one of the risks factors for
hospital-acquired Staphylococcus aureus bacteremia in
hospitalized patients [29]. There is a need for further
studies to investigate the relationship between sNa and
risk of infection also in the general population.
A key question is whether hyponatremia is merely a
marker of severe comorbidities, or is a direct con-
tributor to mortality; similarly, it remains unknownwhether hyponatremia is merely an indicator of decreased
immunological defense related to underlying disease, or
results in increased susceptibility to infection. The present
observational study could not answer this question. Given
that data on urine output for each participant in the
present study were not available, patients whose HD
vintage was less than 12 months were excluded to
decrease the influence of residual renal function with
ADH secretion related to underlying disease on sNa.
Nonetheless, residual confounders may have remained.
An interventional study controlling for sNa is particularly
difficult in ESRD patients, given that a vasopressin V2-
receptor antagonist is not effective in oligoanuric subjects,
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influence pre-dialytic sNa [16]. There are several possible
explanations for the pathophysiological link between sNa
and susceptibility to infection. First, cellular edema of
mucosal membrane associated with extracellular hypoton-
icity and water transfer into the intracellular space may
result in decreased microbial barrier function of the
mucosa in the respiratory, gastrointestinal, or urinary
tract, given that infections of these organs were more fre-
quent in the lower sNa tertile group in the present study
(Figure 1). Second, decreased function of TH17 cells
(interleukin-17 (IL-17)-producing helper T cells) may be
related. TH17 cells and IL-17 play an important role in
host immunity, with the capacity of protection against
extracellular pathogens and fungi, whereas they are also
important drivers of autoimmune disease, and have
inflammatory properties. A recent study showed that
elevated sodium chloride concentration promoted the
differentiation of CD4+ T cells into TH17 cells in vitro,
and a high-salt diet accelerated the development of
autoimmune disease through the activation of TH17 cells
in a mouse model [30]. Similarly, it is possible that ele-
vated sodium chloride concentration increases protective
function against microorganisms, whereas decreased so-
dium chloride concentration or hyponatremia can reduce
it through inhibition of TH17 cells. Further studies are
essential to examine the association of sNa with immu-
nological parameters such as immunoglobulin levels,
cytokine levels, or functions of immunocompetent cells
including TH17 cells in order to clarify whether hypona-
tremia affects the immune system.
The current study had several limitations. First, this
study was an observational, single-center study. Second,
the sample size and the number of outcomes were
limited, and may not be sufficient for generalization to a
larger population. However, the mean sNa was almost
comparable to that of the Japanese population according
to the Dialysis Outcomes and Practice Patterns Study
(DOPPS) [15], and our study population was representa-
tive of the Japanese HD population. The 1st tertile
threshold value of sNa in this study was different from
that in the DOPPS study [15], given the difference in
mean sNa of the whole group. Similarly, the number of
patients in the present study representing each subtype
of IRH was limited, and it was not clear if the asso-
ciation of sNa with risk of IRH was independent of or
specific for infection subtype (Figure 1). A larger cohort
is needed to answer this question. Third, the relationship
between sNa and risk of IRH in a long follow-up period
was examined using only baseline sNa measurement.
More than 3 monthly measurements of sNa were available
during 6 months before IRH in all subjects who experi-
enced IRH (n = 57), and the mean value of the 3 measure-
ments available just before IRH was 137.4 ± 2.8 mEq/L.Although this value was significantly lower than the
baseline value (137.9 ± 2.4 mEq/L) in the paired t-test, the
difference was 0.5 mEq/L. Furthermore, 21 patients out of
26 whose baseline sNa was <138.0 mEq/L (1st sNa tertile)
still had sNa <138.0 mEq/L just before IRH. Thus, the
relationship between baseline sNa and risk of IRH would
remain during a relatively long follow-up period. Fourth,
data on dialysate sodium level for each participant were
not available in the present study, and therefore were not
included in the covariates. However, dialysate sodium level
does not appear to determine pre-dialytic sNa [16], and it
is controversial whether dialysate sodium level according
to sNa is associated with mortality [15]. Finally, data on
volume status that can influence sNa were limited. One to
three monthly post-dialytic measurements of plasma brain
natriuretic peptide were made from May to July 2009 in
257 of the 332 study patients. The mean values were
547 ± 965, 426 ± 667, and 370 ± 401 pg/mL in the 1st,
2nd, and 3rd tertiles, respectively. The differences among
the three groups were not statistically significant, as
assessed by the Kruskal-Wallis H test (p = 0.446).
Conclusions
Lower sNa is an independent predictor of higher risk for
infection-related hospitalization in maintenance HD
patients. Infectious disease may partially account for the
increased mortality observed in the hyponatremic popu-
lation with ESRD.
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